The definitive surgical treatment of portal hypertension secondary to cirrhosis of the liver is intended to lower portal venous pressure and thus prevent hemorrhage from collateral venous channels, usually esophageal varices. Various clinically successful procedures have been developed to shunt the portal blood around the obstructing hepatic vascular bed.1 A disadvantage of the shunting procedures currently in use is the deleterious effect on hepatic function that may follow a reduction in blood supply to the liver. This has been demonstrated experimentally in dogs with Eck fistulas.2,3 Deterioration of hepatic function has also been observed in some patients following portacaval shunt.4,5 By some authors it has been considered problematical whether this hepatic dysfunction might be due to diminution in the total blood supply or simply to diversion of the portal blood.
Silen et al.6 have shown that dogs with a surgical transposition of the portal vein and
OWSLEY JQ, HARPER HA, GOIN JM, CRANE JT, McCORKLE HJ. Transposition of Portal Vein and Inferior Vena Cava in Dogs with Experimental Cirrhosis of the Liver. AMA Arch Surg. 1958;76(5):774–780. doi:10.1001/archsurg.1958.01280230114018
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: